bioMérieux

bioMérieux

バイオテクノロジー研究

Marcy-l'Étoile、Auvergne-Rhône-Alpes329,600人のフォロワー

Pioneering Diagnostics

概要

Pioneering Diagnostics A world leader in the field of in vitro diagnostics for more than 60 years, bioMérieux is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2020, revenues reached €3.1 billion, with over 90% of sales outside of France. bioMérieux provides diagnostic solutions (systems, reagents, software, services) which determine the source of disease and contamination to improve patient health and ensure consumer safety. Its products are mainly used for diagnosing infectious diseases. They are also used for detecting microorganisms in agri-food, pharmaceutical and cosmetic products. bioMérieux is listed on the Euronext Paris stock market. Symbol: BIM – ISIN Code: FR0013280286 Reuters: BIOX.PA/Bloomberg: BIM.FP

ウェブサイト
https://www.biomerieux.com
業種
バイオテクノロジー研究
会社規模
社員 10,001名以上
本社
Marcy-l'Étoile、Auvergne-Rhône-Alpes
種類
上場企業
創立
1963
専門分野
in vitro diagnostics、infectious diseases、reagents、automated instruments、medical analysis、cosmetics、pharmaceutical、industries、healthcare associated infections、molecular biology、microbiology、immunoassays、antimicrobial stewardship、rapid diagnostics、food safety、veterinary diagnostics、blood bank、sepsis

場所

bioMérieuxの社員

アップデート

系列企業ページ

類似するページ